Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC).


Sander J., Janzen N., Terhardt M., Sander S., Gokcay G. F. , Demirkol M., ...Daha Fazla

Clinica chimica acta; international journal of clinical chemistry, cilt.412, ss.134-8, 2011 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 412
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.cca.2010.09.027
  • Dergi Adı: Clinica chimica acta; international journal of clinical chemistry
  • Sayfa Sayıları: ss.134-8

Özet

Background: Quantification of nitisinone, 2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione (NTBC) has been repeatedly described. Nevertheless monitoring of NTBC has not yet become part of routine therapy surveillance in tyrosinaemia type I (OMIM 276700).